OBJECTIVES: High levels of HIV-1 viremia exist in peripheral blood during acute and early infection; however, data on HIV-1 viral loads in female genital secretions during this period are sparse. DESIGN: Prospective cohort of 188 African women with primary HIV-1 infection. METHODS: HIV-uninfected and infected women were followed quarterly; we tested serial plasma specimens by HIV PCR to estimate infection dates. We used the Loess procedure to estimate the magnitude and timing of viral setpoints in plasma and cervical secretions and generalized estimating equations (GEE) to identify predictors of plasma and cervical viral setpoints. RESULTS: We estimated the mean HIV-1 plasma setpoint to be 4.20 log10 HIV-1 RNA copies/ml [95% confidence interval (CI) 4.04-4.35] at 121 days (95% CI 91-137) from infection; an analogous mean cervical viral setpoint was 1.64 log10 HIV-1 RNA copies/swab (95% CI 1.46-1.82) at 174 days (95% CI 145-194) from infection. Cervical loads were significantly higher (0.7-1.1 log10 copies/swab) during acute infection than subsequently. Subtype D infection, pregnancy, breastfeeding, and older age at the time of infection were associated with higher plasma viral setpoint. Subtype C infection, nonviral sexually transmitted infections, having a partner spending nights away from home, recent unprotected sex, and shorter time since infection were associated with higher cervical HIV-1 loads. Hormonal contraception was not associated with either the HIV-1 plasma setpoint or cervical loads during early infection. CONCLUSION: Cervical HIV-1 viral loads were highest during acute infection and then declined up to 6 months following infection, when a 'setpoint' was attained. The prognostic value of a cervical 'setpoint' on future transmission risk remains unclear.
OBJECTIVES: High levels of HIV-1 viremia exist in peripheral blood during acute and early infection; however, data on HIV-1 viral loads in female genital secretions during this period are sparse. DESIGN: Prospective cohort of 188 African women with primary HIV-1 infection. METHODS:HIV-uninfected and infected women were followed quarterly; we tested serial plasma specimens by HIV PCR to estimate infection dates. We used the Loess procedure to estimate the magnitude and timing of viral setpoints in plasma and cervical secretions and generalized estimating equations (GEE) to identify predictors of plasma and cervical viral setpoints. RESULTS: We estimated the mean HIV-1 plasma setpoint to be 4.20 log10 HIV-1 RNA copies/ml [95% confidence interval (CI) 4.04-4.35] at 121 days (95% CI 91-137) from infection; an analogous mean cervical viral setpoint was 1.64 log10 HIV-1 RNA copies/swab (95% CI 1.46-1.82) at 174 days (95% CI 145-194) from infection. Cervical loads were significantly higher (0.7-1.1 log10 copies/swab) during acute infection than subsequently. Subtype D infection, pregnancy, breastfeeding, and older age at the time of infection were associated with higher plasma viral setpoint. Subtype C infection, nonviral sexually transmitted infections, having a partner spending nights away from home, recent unprotected sex, and shorter time since infection were associated with higher cervical HIV-1 loads. Hormonal contraception was not associated with either the HIV-1 plasma setpoint or cervical loads during early infection. CONCLUSION: Cervical HIV-1 viral loads were highest during acute infection and then declined up to 6 months following infection, when a 'setpoint' was attained. The prognostic value of a cervical 'setpoint' on future transmission risk remains unclear.
Authors: G C John; H Sheppard; D Mbori-Ngacha; R Nduati; D Maron; M Reiner; J Kreiss Journal: J Acquir Immune Defic Syndr Date: 2001-02-01 Impact factor: 3.731
Authors: P S Reichelderfer; R W Coombs; D J Wright; J Cohn; D N Burns; S Cu-Uvin; P A Baron; M H Coheng; A L Landay; S K Beckner; S R Lewis; A A Kovacs Journal: AIDS Date: 2000-09-29 Impact factor: 4.177
Authors: A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer Journal: Lancet Date: 2001-11-10 Impact factor: 79.321
Authors: Chia C Wang; R Scott McClelland; Julie Overbaugh; Marie Reilly; Dana DeVange Panteleeff; Kishorchandra Mandaliya; Bhavna Chohan; Ludo Lavreys; Jeckoniah Ndinya-Achola; Joan K Kreiss Journal: AIDS Date: 2004-01-23 Impact factor: 4.177
Authors: Ludo Lavreys; Jared M Baeten; Joan K Kreiss; Barbra A Richardson; Bhavna H Chohan; Wisal Hassan; Dana D Panteleeff; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Julie Overbaugh Journal: J Infect Dis Date: 2004-01-09 Impact factor: 5.226
Authors: Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W Stewart; Li-Ean Goh; Myron S Cohen Journal: J Infect Dis Date: 2004-04-28 Impact factor: 5.226
Authors: Howard Minkoff; Ron Hershow; D Heather Watts; Margaret Frederick; Irene Cheng; Ruth Tuomala; Jane Pitt; Carmen D Zorrilla; Hunter Hammill; Samuel K Adeniyi-Jones; Bruce Thompson Journal: Am J Obstet Gynecol Date: 2003-08 Impact factor: 8.661
Authors: Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia Journal: J Clin Invest Date: 2016-02-08 Impact factor: 14.808
Authors: Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata Journal: J Acquir Immune Defic Syndr Date: 2011-06-01 Impact factor: 3.731
Authors: Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker Journal: AIDS Res Hum Retroviruses Date: 2014-11-19 Impact factor: 2.205
Authors: Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Eric Arts; Immaculate Nankya; Robert A Salata; Veronica Franco; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker Journal: J Acquir Immune Defic Syndr Date: 2014-04-01 Impact factor: 3.731
Authors: Kathryn E Lancaster; Cynthia Kwok; Anne Rinaldi; Josaphat Byamugisha; Tulani Magwali; Prisca Nyamapfeni; Robert A Salata; Charles S Morrison Journal: Int J Gynaecol Obstet Date: 2015-09-08 Impact factor: 3.561
Authors: Susan A Fiscus; Susan Cu-Uvin; Abel Tilahun Eshete; Michael D Hughes; Yajing Bao; Mina Hosseinipour; Beatriz Grinsztejn; Sharlaa Badal-Faesen; Joan Dragavon; Robert W Coombs; Ken Braun; Laura Moran; James Hakim; Timothy Flanigan; N Kumarasamy; Thomas B Campbell Journal: Clin Infect Dis Date: 2013-03-26 Impact factor: 9.079
Authors: Christine Mauck; Pai-Lien Chen; Charles S Morrison; Raina N Fichorova; Cynthia Kwok; Tsungai Chipato; Robert A Salata; Gustavo F Doncel Journal: AIDS Res Hum Retroviruses Date: 2016-01-26 Impact factor: 2.205
Authors: Megan Justine Huchko; Victoria Woo; Teri Liegler; Anna Leddy; Karen Smith-McCune; George F Sawaya; Elizabeth A Bukusi; Craig R Cohen Journal: J Low Genit Tract Dis Date: 2013-07 Impact factor: 1.925